CELERA Logo
CELERA Skin Substitute

What is EMERGE?

EMERGE™ Allografts are intended for use as a barrier or wound cover. They support the healing cascade and protect the wound bed to aid in the development of granulation tissue in acute and chronic wounds.1

Get started with EMERGE today!

EMERGE allografts provide a human biocompatible extracellular matrix (ECM)

EMERGE amnion chorion membrane allografts are minimally manipulated and dehydrated. They retain the structural and functional characteristics of native placental membranes.

EMERGE allografts (361 HCT/Ps) are intended for use as a barrier or wound cover. EMERGE allografts are intended for use by qualified healthcare professionals for application in a physician office, outpatient, or inpatient setting.

EMERGE Product Benefits

Product Advantages

  • Easy to apply
  • Shelf-stable*
  • 5-year shelf life
  • Terminally sterilized for additional level of safety
  • Compatible with compression therapy, Negative Pressure Wound Therapy (NPWT) and Hyperbaric Oxygen Therapy (HBOT)

*See Instructions for Use

Clinical Use Examples

  • Acute Wounds
  • Chronic Wounds
  • Post-Debridement
  • Dehisced Wounds
  • Diabetic Foot Ulcers (DFUs)
  • Venous Leg Ulcers (VLUs)
  • Pressure Ulcers (PUs)
  • Mohs Repair
  • Deep or Tunneling Wounds

    EMERGE™ (Q4297)

    Dual Membrane Placental Derived Matrix
    PART NUMBER SIZE SQ CM UPC/GTIN
    EME-26222 2 cm x 2 cm  sheet 4 850046045615
    EME-26223 2 cm x 3 cm  sheet 6 850046045622
    EME-26224 2 cm x 4 cm sheet 8 850046045646
    EME-26244 4 cm x 4 cm sheet 16 850046045653
    EME-26246 4 cm x 6 cm sheet 24 850046045639
    EME-26248 4 cm x 8 cm sheet 32 850046045660
    EME-26920 9 cm x 20 cm sheet 180 850046045677

    Our Products

    Click the toggle below to view our product solutions by:

    REFERENCES: 1. Niknejad H, Peirovi H, Jorjani M, Ahmadiani A, Ghanavi J, Seifalian AM. Properties of the amniotic membrane for potential use in tissue engineering. Eur Cell Mater. 2008;15:88-99.